The objective of the Transgenic Core is to provide transgenic mice to members of the COBRE program. The availability of this Core will provide state-of-the-art technologies to investigators of the VLC-COBRE and to the other life scientists at UVM. In addition to the generation, maintenance and screening of new transgenic mice, this Core aims to establish the techniques required for the generation of knock out mice at the University of Vermont.
The specific aims of this core are: 4. To provide a core service for the generation of transgenic F2 mice. 5. To maintain a common SPF colony of transgenic mice that will be used in several projects. 6. To develop a regulated expression of genes in the airways of transgenic mice. 7. To establish embryonic stem cell cultures and techniques necessary to make gene deficient stem cells. 8. To establish the blastocyst injection techniques to generate knock out mice. 9. To establish a training course to enable the University of Vermont faculty, stuff and students to learn the bases and applications of the use of transgenic and knock out mice.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Exploratory Grants (P20)
Project #
1P20RR015557-01
Application #
6370602
Study Section
Special Emphasis Panel (ZRR1)
Project Start
2000-09-30
Project End
2005-08-31
Budget Start
Budget End
Support Year
1
Fiscal Year
2000
Total Cost
Indirect Cost
Name
University of Vermont & St Agric College
Department
Type
DUNS #
066811191
City
Burlington
State
VT
Country
United States
Zip Code
05405
Szalayova, Gabriela; Ogrodnik, Aleksandra; Spencer, Brianna et al. (2016) Human breast cancer biopsies induce eosinophil recruitment and enhance adjacent cancer cell proliferation. Breast Cancer Res Treat 157:461-74
Cruz, Fernanda F; Borg, Zachary D; Goodwin, Meagan et al. (2016) CD11b+ and Sca-1+ Cells Exert the Main Beneficial Effects of Systemically Administered Bone Marrow-Derived Mononuclear Cells in a Murine Model of Mixed Th2/Th17 Allergic Airway Inflammation. Stem Cells Transl Med 5:488-99
Ather, Jennifer L; Burgess, Edward J; Hoyt, Laura R et al. (2016) Uricase Inhibits Nitrogen Dioxide-Promoted Allergic Sensitization to Inhaled Ovalbumin Independent of Uric Acid Catabolism. J Immunol 197:1720-32
Menon, Prema R; Stapleton, Renee D; McVeigh, Ursula et al. (2015) Telemedicine as a tool to provide family conferences and palliative care consultations in critically ill patients at rural health care institutions: a pilot study. Am J Hosp Palliat Care 32:448-53
Kasahara, David I; Ninin, Fernanda M C; Wurmbrand, Alison P et al. (2015) Abrogation of airway hyperresponsiveness but not inflammation by rho kinase insufficiency. Clin Exp Allergy 45:457-70
Lathrop, M J; Sage, E K; Macura, S L et al. (2015) Antitumor effects of TRAIL-expressing mesenchymal stromal cells in a mouse xenograft model of human mesothelioma. Cancer Gene Ther 22:44-54
Dixon, Anne E; Gerald, Lynn B (2015) Promoting weight loss in asthma. Respirology 20:179-80
Cruz, Fernanda F; Borg, Zachary D; Goodwin, Meagan et al. (2015) Freshly thawed and continuously cultured human bone marrow-derived mesenchymal stromal cells comparably ameliorate allergic airways inflammation in immunocompetent mice. Stem Cells Transl Med 4:615-24
Cruz, Fernanda F; Borg, Zachary D; Goodwin, Meagan et al. (2015) Systemic Administration of Human Bone Marrow-Derived Mesenchymal Stromal Cell Extracellular Vesicles Ameliorates Aspergillus Hyphal Extract-Induced Allergic Airway Inflammation in Immunocompetent Mice. Stem Cells Transl Med 4:1302-16
Lathrop, Melissa J; Brooks, Elice M; Bonenfant, Nick R et al. (2014) Mesenchymal stromal cells mediate Aspergillus hyphal extract-induced allergic airway inflammation by inhibition of the Th17 signaling pathway. Stem Cells Transl Med 3:194-205

Showing the most recent 10 out of 158 publications